Redeye: Fortnox - ARPC Growth Back on Track
Redeye retains its positive view and Base Case for Fortnox despite lowered short-term EBIT margins. While increasing investments raise our cost assumptions, the comeback in ARPC growth combined with management’s positive outlook for Fortnox Finance makes us more confident in our sales growth forecasts.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/